Strides Pharma Scien Latest News

  1. The company has 124 cumulative ANDA filings with USFDA of which 87 ANDAs have been approved and 37 are pending approval
    Date:09-07-2020
  2. Strides Pharma Science has informed that it has enclosed a press release on 9th 2020 issued by the Company titled ‘Strides receives USFDA approval for   Butalbital, Acetaminophen, Caffeine, a...

    Date:09-07-2020
  3. The company has 124 cumulative ANDA filings with USFDA of which 87 ANDAs have been approved and 37 are pending approval
    Date:09-07-2020
  4. The product will be manufactured at the company’s flagship facility at Bangalore
    Date:02-06-2020
  5. The product is a generic version of Avigan of Toyama Chemical, Japan
    Date:29-04-2020
  6. The product is a generic version of Avigan of Toyama Chemical, Japan
    Date:29-04-2020
  7. The product will be manufactured at the company’s flagship facility at Bangalore and will be marketed by Strides Pharma Inc. in the US market
    Date:20-04-2020
  8. The US health regulator has asked all manufacturers to withdraw the drugs from the market immediately
    Date:03-04-2020
  9. Receipt of EIR confirms the successful closure of the inspections
    Date:30-03-2020
  10. Receipt of EIR confirms the successful closure of the inspections
    Date:30-03-2020
Return to Top
Puchho Befikar